Company Overview and News

 
Videocon Industries Limited - News Clarification

2018-04-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Videocon Industries Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
Market Update: CNX IT zooms 3.7% as TCS, Infosys jumps over 2%; Nifty PSU bank falls 3%; Jubilant Food at new 52-week high

2018-04-12 moneycontrol
The Indian equity market was trading on a positive note on Thursday morning with the Nifty adding 20 points at 10,421 mark while the Sensex was up 51 points or 0.14 percent.
Upvote Downvote

 
Rajiv Kochhar quizzed for third day in a row

2018-04-08 freepressjournal.in
The CBI also grilled Mahesh Chandra Punglia, Director of NuPower Renewables Pvt Ltd, during the preliminary enquiry.
Upvote Downvote

 
Videocon-ICICI loan case: CBI continues to question Chanda Kochhar’s brother-in-law Rajiv Kochhar

2018-04-07 freepressjournal.in
Mumbai: Rajiv Kochhar, the brother-in-law of Chanda Kochhar, the Managing Director and Chief Executive Officer of ICICI bank was questioned again by the Central Bureau of Investigation on Friday again in the alleged irregularities for amassing wrongful personal gains after ICICI bank sanctioned loans worth Rs.3,250 crore to the Videocon Industries Limited.
Upvote Downvote

 
ICICI Bank says no individual loans given to any of the 5 firms in Videocon Group

2018-04-04 moneycontrol
ICICI Bank did not give individual loans to any of the five companies in the Videocon Group, the private sector lender informed the stock exchanges on Wednesday.
Upvote Downvote

 
Videocon Industries Limited - News Clarification

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
ICICI Bank chief Chanda Kochhar’s name dropped from FICCI event to be attended by President Kovind

2018-04-03 freepressjournal.in
New Delhi: ICICI Bank chief Chanda Kochhar’, who is the middle of a controversy for granting a loan to the Videocon Group, has been dropped from the invitees’ list of an event by industry chamber FICCI on April 5 which will be attended by President Ram Nath Kovind.
Upvote Downvote

 
Market Update: PSU bank index rallies as SBI, BoB jump 2-3%; HPCL top gainer, Delta Corp jumps 6%, metals drag

2018-04-03 moneycontrol
The Indian equity market were trading on a positive note on Tuesday morning with the Nifty adding 3 points at 10,215 mark while the Sensex was up 28 points or 0.07 percent.
Upvote Downvote

 
Goldman Sachs files suit to recover Rs36 crore from Videocon

2018-04-02 livemint
Mumbai: Goldman Sachs has approached the bankruptcy court in Mumbai to recover around $5.6 million (Rs 36 crore) from Videocon Industries Ltd.
Upvote Downvote

 
Avista founder denies business dealings with ICICI Bank

2018-04-02 livemint
Mumbai: Less than a week after ICICI Bank Ltd mounted a defence of Chanda Kochhar against allegations of financial impropriety, its chief executive officer found herself in the eye of the storm again, with senior Bharatiya Janata Party (BJP) leader Subramanian Swamy calling for a probe into the dealings of financial services firm Avista Advisory Group with ICICI Bank.
Upvote Downvote

 
Whistleblower in ICICI Bank-Videocon case calls for check on lending practices across banks

2018-04-02 moneycontrol
Arvind Gupta, the whistleblower in the ICICI Bank-Videocon Group controversy, wants the government and regulators to check on the lending practices of the banking system.
Upvote Downvote

 
Videocon Industries Limited - News Verification

2018-04-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
Upvote Downvote

 
CBI initiates enquiry against ICICI Bank CEO Chanda Kochhar’s husband Deepak

2018-04-01 freepressjournal.in
Mumbai : The CBI has started a preliminary enquiry (PE) against Chanda Kochhar’s husband Deepak Virendra Kochhar. This comes after ICICI bank shareholder Arvind Gupta accused Kochhar of allegedly amassing wrongful personal gains after ICICI Bank sanctioned loans worth Rs 3,250 crore to various private companies belonging to the Videocon Industries Limited.
Upvote Downvote

 
ICICI Bank loan issue under Sebi scanner

2018-03-31 freepressjournal.in
New Delhi : With ICICI Bank embroiled in a controversy over alleged conflict of interest involving its CEO Chanda Kochhar, market regulator Sebi has begun looking into the matter for any possible disclosure and corporate governance-related lapses.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...